Magnetization transfer contrast (MTC) imaging has been used to study neuromelanin (NM) in Parkinson’s disease. By suppressing the background tissue using an MTC pulse in a T1W sequence, the NM becomes visible, supposedly because of its reduced T1. However, we show using STAGE (strategically acquired gradient echo) imaging with/without an MTC pulse that this is not the reason for its visibility. Rather, it is the increased water content relative to surrounding tissue that keeps the signal high. Using the appropriate choice of flip angles and resolution, the NM contrast on MTC images can be significantly increased.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords